Matrix Medical Communications

The Journal of Clinical and Aesthetic Dermatology

Health EN ↓ 63 episodes

JCAD's audio platform provides interviews with leading experts in the dermatology field.

Author

Matrix Medical Communications

Episodes

Nicole Keeter, MSHS, PA-C: Incorporating Topical and Oral Treatments into Your Practice 21.11.2022 2:47

Send us Fan Mail Nicole Keeter, MSHS, PA-C, describes how to implement various JAK inhibitors into practice for the treatment of atopic dermatitis, psoriasis, and alopecia areata. She discusses how utilizing these JAK inhibitors in the treatment of atopic dermatitis has shown to provide a rapid decrease in symptoms, particularly pruritus.

Nicole Keeter, MSHS, PA-C: Focusing on Safety Consideration for the Prescription of JAK Inhibitors 27.10.2022 3:09

Send us Fan Mail After reviewing notable safety considerations for systemic and topical Janus kinase inhibitors for patients with atopic dermatitis, Nicole Keeter, PA-C, describes steps she has taken to become more comfortable prescribing these agents to her patients with AD and discusses important tips for counseling these patients on adverse events and black box warnings.

James Del Rosso, DO: Topical Treatment for Atopic Dermatitis 20.09.2022 3:39

Send us Fan Mail Dr. James Del Rosso reviews various common treatments for atopic dermatitis, specifically topical agents that have demonstrated effectiveness for patients.

Peter Lio, MD: The Evolution of Topical JAK Inhibitors 25.08.2022 2:59

Send us Fan Mail Peter Lio, MD, Assistant Professor of Clinical Dermatology and Pediatrics at Northwestern University’s Feinberg School of Medicine, discusses the development of JAK inhibitors over the years, and reviews the increase in reliability among both oral and topical treatments for atopic dermatitis.

James Del Rosso, DO: The Benefits of Topical JAK Inhibitors 09.08.2022 2:35

Send us Fan Mail Dr. James Del Rosso discusses the benefits of topical JAK inhibitors over oral JAK inhibitors for the treatment of atopic dermatitis.

Lisa Swanson, MD: Things to Consider When Starting Patients on JAK Inhibitors 23.06.2022 4:34

Send us Fan Mail Lisa Swanson, MD, a board-certified dermatologist and pediatric dermatologist with Ada West Dermatology in Boise, Idaho, reviews the role that Janus kinases (JAKs) play in the inflammatory process and the benefits of inhibiting this enzyme when treating patients with atopic dermatitis. She also elaborates upon her experiences using the newly approved JAK inhibitors in her own pati...

Lisa Swanson, MD: Counseling Patients on JAK Inhibitors 03.05.2022 6:12

Send us Fan Mail Lisa Swanson, MD, a board-certified dermatologist and pediatric dermatologist with Ada West Dermatology in Boise, Idaho, discusses how she intends to incorporate newly approved JAK inhibitors into her atopic dermatitis treatment algorithm and her strategies for patient counseling when treating with these agents.

Doris Day, MD: The Effect of Stress on Hair Health 19.04.2022 2:32

Send us Fan Mail Dr. Day discusses the effect of stress on hair health.

Raj Chovatiya, MD, PhD: Discussing Atopic Dermatitis Treatment Risks with Patients 08.03.2022 2:22

Send us Fan Mail Raj Chovatiya, MD, PhD, Director of the Center for Eczema and Itch at the Department of Dermatology at Northwestern University Feinberg School of Medicine, discusses how he addresses questions from his patients with AD regarding potential adverse events and warnings associated with treatments for AD.

Douglas DiRuggiero, DMSc, PA-C: Safety of JAK Inhibitors for Atopic Dermatitis 21.12.2021 4:38

Send us Fan Mail Douglas DiRuggiero, DMSc, PA-C, discusses the exciting renaissance occurring in the realm of topical treatments for atopic dermatitis.

Matt Zirwas, MD: Patient Preparatory Guidance for Topical JAK Inhibitors 21.12.2021 2:13

Send us Fan Mail Matthew Zirwas, MD, provides guidance on speaking with patients with atopic dermatitis about treating their condition with topical JAK inhibitors.

Matt Zirwas, MD: An Overview of Janus-kinase (JAK) inhibitors for Atopic Dermatitis 01.12.2021 2:15

Send us Fan Mail Matthew Zirwas, MD, discusses the efficacy, benefits, and safety profile of topical and systemic JAK inhibitors for the treatment of atopic dermatitis.

Douglas DiRuggiero, DMSc, PA-C: An Overview of JAK Inhibitors for Atopic Dermatitis 01.12.2021 2:21

Send us Fan Mail Douglas DiRuggiero, DMSc, PA-C, discusses the mechanism of action and efficacy of topical and systemic JAK inhibitors for the treatment of atopic dermatitis.